| Protocol # | Sponsor | Protocol TItle |
|---|---|---|
| NCT01772004 | EMD Serono EMR 100070-001, 2013-002834-19 | A Phase I, Open-label, Multiple-Ascending Dose Trial to Investigate the Safety, Tolerability, Pharmacokinetics, Biological and Clinical Activity of Avelumab (MSB0010718C) in Subjects With Metastatic or Locally Advanced Solid Tumors and Expansion to Selected Indications |
